- Home
- FBRX vs BTMD Comparison
FBRX vs BTMD Comparison
Compare FBRX & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- BTMD
- Stock Information
- Founded
- FBRX N/A
- BTMD 2012
- Country
- FBRX United States
- BTMD United States
- Employees
- FBRX N/A
- BTMD N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- FBRX Health Care
- BTMD Health Care
- Exchange
- FBRX Nasdaq
- BTMD Nasdaq
- Market Cap
- FBRX 154.5M
- BTMD 127.8M
- IPO Year
- FBRX N/A
- BTMD N/A
- Fundamental
- Price
- FBRX $11.60
- BTMD $4.32
- Analyst Decision
- FBRX Strong Buy
- BTMD Strong Buy
- Analyst Count
- FBRX 2
- BTMD 1
- Target Price
- FBRX $61.00
- BTMD $8.00
- AVG Volume (30 Days)
- FBRX 73.6K
- BTMD 110.5K
- Earning Date
- FBRX 08-13-2025
- BTMD 08-07-2025
- Dividend Yield
- FBRX N/A
- BTMD N/A
- EPS Growth
- FBRX N/A
- BTMD 201.68
- EPS
- FBRX N/A
- BTMD 0.60
- Revenue
- FBRX N/A
- BTMD $199,379,000.00
- Revenue This Year
- FBRX N/A
- BTMD $5.87
- Revenue Next Year
- FBRX N/A
- BTMD $8.59
- P/E Ratio
- FBRX N/A
- BTMD $7.20
- Revenue Growth
- FBRX N/A
- BTMD 6.44
- 52 Week Low
- FBRX $4.11
- BTMD $3.04
- 52 Week High
- FBRX $28.68
- BTMD $8.06
- Technical
- Relative Strength Index (RSI)
- FBRX 53.91
- BTMD 59.00
- Support Level
- FBRX $10.02
- BTMD $3.98
- Resistance Level
- FBRX $10.99
- BTMD $4.25
- Average True Range (ATR)
- FBRX 0.86
- BTMD 0.20
- MACD
- FBRX -0.06
- BTMD 0.01
- Stochastic Oscillator
- FBRX 60.78
- BTMD 87.11
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.